Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-08

Tsigereda Weldemichael

Role not yet determined Is this you? Add your title

Also affiliated: Tianjin University (2022)

5 h-index 8 pubs 146 cited

  • Humans
  • Kidney
  • Animals
  • Endocytosis
  • CD36 Antigens
  • Leukemia, Myeloid, Acute
  • Protein Kinase Inhibitors
  • Antibiotics, Antineoplastic
  • Kidney Diseases
  • Anthracyclines
  • Protective Agents
  • Acute Kidney Injury
  • Hemodynamics
  • Hepatorenal Syndrome
  • Renal Circulation

Biography and Research Information

OverviewAI-generated summary

Tsigereda Weldemichael's research investigates mechanisms of drug delivery and therapeutic interventions, with a focus on kidney diseases and cancer. Her work includes studying the CD36-mediated endocytosis of proteolysis-targeting chimeras and the delivery efficiency of oligonucleotides using lipid conjugation. Weldemichael has also explored renoprotective approaches against anthracycline nephrotoxicity and the impact of specific compounds, such as EET-based therapeutics, on mitigating drug-induced cellular damage in the kidneys. Her recent publications also touch on synthetic biology applications and industrial uses of enzymes. Weldemichael collaborates with researchers at the University of Arkansas for Medical Sciences, including Abdul H. Khan and Phuc Tran, and at the University of Arkansas at Fayetteville, including Samaneh Goorani.

Metrics

  • h-index: 5
  • Publications: 8
  • Citations: 146

Selected Publications

  • Renal hemodynamics underlie hepatorenal physiology in bile duct-ligated rats (2026)
    Clinical Science 1 citation DOI OpenAlex
  • Renoprotective approaches against anthracycline nephrotoxicity (2026)
    Biochemical Pharmacology 2 citations DOI OpenAlex
  • EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage (2025)
    Biomolecules DOI OpenAlex
  • Insect‐Microbe‐Based Laccase: Untapped Natural Resource for Industrial and Biotechnological Applications (2025)
    Advanced Sustainable Systems 5 citations DOI OpenAlex
  • CD36-mediated endocytosis of proteolysis-targeting chimeras (2025)
    Cell 58 citations DOI OpenAlex
  • An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L (2023)
    European Journal of Medicinal Chemistry 10 citations DOI OpenAlex
  • Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome (2022)
    Pharmaceutics 49 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

50 Collaborators 23 Institutions 8 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics